Member access

4-Traders Homepage  >  Shares  >  Xetra  >  MorphoSys AG    MOR   DE0006632003

MORPHOSYS AG (MOR)

44
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
04/28/2015 04/29/2015 04/30/2015 05/04/2015 05/05/2015 Date
65.79(c) 65.59(c) 64.43(c) 67.48(c) 63.42 Last
198 042 290 736 218 438 149 394 223 545 Volume
-1.88% -0.30% -1.77% +4.73% -6.02% Change
More quotes
Financials (€)
Sales 2015 105 M
EBIT 2015 0,09 M
Net income 2015 -1,70 M
Finance 2015 293 M
Yield 2015 -
Sales 2016 62,4 M
EBIT 2016 13,9 M
Net income 2016 5,67 M
Finance 2016 270 M
Yield 2016 -
PER 2015 301,92
PER 2016 260,94
EV / Sales 2015 14,3x
EV / Sales 2016 24,3x
Capitalization 1 786 M
More Financials
Company
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications.It operates through the following segments: Partnered Discovery, Proprietary Development, and AbD Serotec.The Partnered Discovery segment involves technologies for the generation of human... 
Sector
Biotechnology & Medical Research
Calendar
05/05 | 01:00amEarnings Release
More about the company
Surperformance© ratings of MorphoSys AG
Trading Rating : Investor Rating :
More Ratings
Latest news on MORPHOSYS AG
01:02a MORPHOSYS : AG Reports Results for the First Three Months of 2015
04/29 MORPHOSYS : to Host Q1 2015 Conference Call on 05 May 2015
04/29 MORPHOSYS : to Host Q1 2015 Conference Call on 05 May 2015
04/14 MORPHOSYS : to Present at Kempen & Co Life Sciences Conference
04/14 MORPHOSYS : to Present at Kempen & Co Life Sciences Conference
04/13 MORPHOSYS : to Receive Milestone Payment for Guselkumab Program in Psoriatic Art..
04/13 MORPHOSYS : AG : to Receive Milestone Payment for Guselkumab Program in Psoriati..
04/09 MORPHOSYS : to Start Share Buy-Back Program
More news
Sector news : Biotechnology & Medical Research - NEC
04:01p QIAGEN NV : Reports Results for First Quarter 2015
02:25pDJAbbVie Launches Large Debt Sale for Pharmacyclics Deal
02:10pDJAbbVie Launches Large Debt Sale for Pharmacyclics Deal
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
02:35p MorphoSys's (MPSYF) CEO Seth Fischer on Q1 2015 Results - Earnings Call Trans..
04/17 CELGENE : A Pre-Earnings Discussion Based On Recent News
02/26 MorphoSys' (MPSYF) CEO Simon Moroney on Q4 2014 Results - Earnings Call Trans..


Comments 
Advertisement
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MOR | DE0006632003 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF